Intracranial hemorrhage
Conditions
Interventions
Observation group:None
Sponsors
The First Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Subjects aged 18–65 years, of any gender; 2.no history of cerebral hemorrhage or neurological disorders; 3.no severe liver or kidney dysfunction, immune system diseases, or tumor history; 4.no coagulation disorders or current use of anticoagulant medications; 5.voluntarily participate in the study and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1.Subjects with a history of bleeding disorders or recent bleeding; 2.currently taking drugs that affect coagulation or immune function; 3.suffering from severe chronic diseases (such as liver cirrhosis, kidney failure, malignant tumors, etc.); 4.pregnant or breastfeeding women; 5.with mental illness or cognitive impairment that makes it impossible to sign the informed consent form;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The concentration of C1q protein in peripheral blood serum; | — |
Secondary
| Measure | Time frame |
|---|---|
| The concentration of C1q protein in peripheral blood plasma; | — |
Countries
China
Contacts
Public ContactHaiying Li
The First Affiliated Hospital of Soochow University
Outcome results
None listed